Recent progresses in regenerative medicine and stem cell science provide new approaches to innovative therapeutics such as cell-based therapeutic products derived from iPS cells, ES cells or somatic (stem) cells. We are engaged in the studies on the evaluation of the quality, safety and efficacy of cell-based therapeutic products. Biochemical and molecular biological studies related with this field are also conducted at the division.